TARACTAN Drug Patent Profile
✉ Email this page to a colleague
When do Taractan patents expire, and what generic alternatives are available?
Taractan is a drug marketed by Roche and is included in three NDAs.
The generic ingredient in TARACTAN is chlorprothixene. Additional details are available on the chlorprothixene profile page.
Summary for TARACTAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Patent Applications: | 4,359 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TARACTAN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TARACTAN
US Patents and Regulatory Information for TARACTAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | TARACTAN | chlorprothixene | CONCENTRATE;ORAL | 016149-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Roche | TARACTAN | chlorprothixene | TABLET;ORAL | 012486-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Roche | TARACTAN | chlorprothixene | INJECTABLE;INJECTION | 012487-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
